No increase in risk of coronavirus disease 2019 in people with multiple sclerosis

Takeaway

  • There is no increased risk of coronavirus disease 2019 (COVID-19) infection observed in people with multiple sclerosis (MS) or neuromyelitis optica spectrum disorders (NMOSD), irrespective of whether they use disease-modifying drugs.

Why this matters

    The results add further knowledge on which people are at higher risk of COVID-19 infection, so the correct procedures and clinical practices can take place.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.